帕金森病的水上有氧运动处方:一个范围审查
Giovanna Cristina Leveck1, Taina Christinelli1, Stephany Ferreira de Souza1
1Universidade Federal Do Paraná, Postgraduate Program in Physical Education, Curitiba, Paraná, Brazil.
Journal of bodywork and movement therapies
|May 6, 2025
概括
水上有氧运动在帕金森病 (PD) 症状管理方面表现有前途. 然而,目前的研究缺乏标准化的运动处方,需要进一步研究PD患者的最佳水中运动方案.
科学领域:
- 神经科学是一个神经科学.
- 运动生理学 运动生理学
- 康复科学 康复科学 康复科学
背景情况:
- 帕金森病 (PD) 涉及多巴胺基神经元退化,导致运动和非运动症状,损害生活质量.
- 水上有氧运动是稳定PD症状和进展的潜在治疗策略.
- 准确的运动疗法处方至关重要,但缺乏PD的全面文献.
研究的目的:
- 系统地审查有关帕金森病患者水上有氧运动处方的科学文献.
- 分析持续时间,运动干预的类型,强度控制方法,以及现有研究中评估的主要结果.
- 为了确定文献中的空白,关于PD的标准化水上运动协议.
主要方法:
- 一个系统的文献审查,遵循PRISMA-ScR指南,在开放科学框架上注册.
- 在PubMed,PEDro,Sciencedirect和Web of Science进行了搜索,寻找过去10年内发表的研究.
- 选择了描述PD水上有氧运动计划的研究,数据提取侧重于干预细节和结果.
主要成果:
- 在1642项已识别的研究中,有9项符合入选资格标准.
- 选择的研究共涉及215名患有帕金森病的参与者,从Hoehn Yahr尺度阶段1到4.
- 关于运动类型,持续时间,强度控制和结果指标的关键数据被提取和分析.
结论:
- 目前的文献没有为帕金森病的水中有氧运动提供标准的处方.
- 需要进一步的研究,以建立基于证据的指导方针,用于PD管理中的水生炼干预措施.
- 运动处方的标准化对于优化PD患者水上有氧运动的治疗益处至关重要.
相关概念视频
01:24Parkinson's Disease: Treatment
154
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
154
01:15Parkinson's Disease: Overview
319
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
319
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
109
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
109
01:17Exercise and Cardiac Output
708
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
708
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
88
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
88
01:20Exercise and Cardiovascular Response
650
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
650